Background Testicular germ cell cancer (TGCC), being the most frequent malignancy in young Caucasian males, is initiated from an embryonic germ cell. This study determines intratumour heterogeneity to unravel tumour progression from initiation until metastasis. Methods In total, 42 purified samples of four treatment-resistant nonseminomatous (NS) TGCC were investigated, including the precursor germ cell neoplasia in situ (GCNIS) and metastatic specimens, using whole-genome and targeted sequencing. Their evolution was reconstructed. Results Intratumour molecular heterogeneity did not correspond to the supposed primary tumour histological evolution. Metastases after systemic treatment could be derived from cancer stem cells not identified in the primary cancer. GCNIS mostly lacked the molecular marks of the primary NS and comprised dominant clones that failed to progress. A BRCA-like mutational signature was observed without evidence for direct involvement of BRCA1 and BRCA2 genes. Conclusions Our data strongly support the hypothesis that NS is initiated by whole-genome duplication, followed by chromosome copy number alterations in the cancer stem cell population, and accumulation of low numbers of somatic mutations, even in therapy-resistant cases. These observations of heterogeneity at all stages of tumourigenesis should be considered when treating patients with GCNIS-only disease, or with clinically overt NS.

Additional Metadata
Persistent URL dx.doi.org/10.1038/s41416-019-0381-1, hdl.handle.net/1765/115346
Journal British Journal of Cancer
Citation
Dorssers, L.C.J, Gillis, A.J.M, Stoop, H., van Marion, R, Nieboer, M.M., van Riet, J, … Looijenga, L.H.J. (2019). Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development. British Journal of Cancer, 120(4), 444–452. doi:10.1038/s41416-019-0381-1